Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Alcobra Ltd. Ord (ADHD)

10.22 0.42 (4.29%)

11-15 16:00

Open:

1.4

Pre. Close:

9.8

High:

1.64

Low:

1.4

Volume:

1,107,893

Market Cap:

282M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

10.45 - 10.63

10.63 - 10.75

Low:

1.35 - 1.37

1.37 - 1.38

Close:

10.01 - 10.31

10.31 - 10.5

Technical analysis  (as of: 2017-11-24 1:52:44 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 12.12     One year: 14.16

Support:

Support1: 4.58    Support2:

Resistance:

Resistance1: 10.38    Resistance2: 12.12

Pivot:

2.60

Moving Averages:

MA(5): 4.89     MA(20): 2.33

MA(100): 1.34     MA(250): 1.37

MACD:

MACD(12,26): 1.27     Signal(12,26,9): 0.42

%K %D:

%K(14,3): 75.11     %D(3): 54.78

RSI:

RSI(14): 94.70

52-Week:

High: 10.38  Low: 0.83  Change(%): 393.1

Average Vol(K):

3-Month: 196904  10-Days 35769

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ADHD has closed above the upper band by 12.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 2925.2% wider than normal. The large width of the bands suggest high volatility as compared to ADHD's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Wed, 27 Sep 2017 22:18:45 GMT
Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge

Thu, 16 Nov 2017 12:00:00 GMT
Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and ...

Thu, 19 Oct 2017 11:02:33 GMT
Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson ...

Tue, 31 Oct 2017 12:00:00 GMT
Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to ...

Fri, 06 Oct 2017 12:00:00 GMT
Arcturus Therapeutics, Inc. to Present at the Chardan Gene Therapy Conference

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

27.56

Shares Float (M)

14.23

% Held by Insiders

20.64

% Held by Institutions

31.93

Shares Short (K)

1040

Shares Short Prior Month (K)

1150

Stock Financials

EPS

-0.760

EPS Est. Current Year

-0.770

EPS Est. Next Year

-0.680

EPS Est. Next Quarter

-0.220

Forward EPS

-4.776

Book Value (p.s.)

1.480

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-25.5

Return on Equity (ttm)

-41.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.777

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.70

Levered Free Cash Flow (M)

-12.46

atoplab.com

Valuation

P/E

-13.17

P/E Growth Ratio

-0.02

P/BV

6.76

P/S

P/CF

-14.00

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-11-16

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.